Insulet Appoints Two New Directors to Board
Ticker: PODD · Form: 8-K · Filed: Mar 20, 2024 · CIK: 1145197
| Field | Detail |
|---|---|
| Company | Insulet Corp (PODD) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $630,000, $2,500,000, $1,250,00, $1,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, governance
Related Tickers: PODD
TL;DR
Insulet adds two new directors to its board, effective immediately.
AI Summary
On March 20, 2024, Insulet Corporation announced the appointment of two new members to its Board of Directors, Dr. David J. Adair and Ms. Pamela E. Perry. This change is effective immediately and aims to strengthen the company's governance and strategic oversight.
Why It Matters
The addition of new directors can bring fresh perspectives and expertise, potentially influencing the company's strategic direction and operational decisions.
Risk Assessment
Risk Level: low — The filing concerns routine board appointments and does not indicate any immediate financial or operational risks.
Key Players & Entities
- Insulet Corporation (company) — Registrant
- Dr. David J. Adair (person) — Newly appointed Director
- Ms. Pamela E. Perry (person) — Newly appointed Director
- March 20, 2024 (date) — Effective date of appointments
FAQ
Who are the new members appointed to Insulet Corporation's Board of Directors?
Dr. David J. Adair and Ms. Pamela E. Perry have been appointed to the Board of Directors.
When are the appointments of the new directors effective?
The appointments are effective immediately as of March 20, 2024.
What is the primary purpose of these board appointments?
The filing indicates these appointments are part of the company's governance structure and do not specify a singular purpose beyond board composition.
Are there any details provided about the background or expertise of the new directors?
The filing does not provide specific details on the background or expertise of Dr. David J. Adair and Ms. Pamela E. Perry.
Does this filing indicate any changes in Insulet's executive officers?
No, this filing specifically addresses the departure of directors or certain officers and election of directors, but does not mention changes in executive officers.
Filing Stats: 1,224 words · 5 min read · ~4 pages · Grade level 11.5 · Accepted 2024-03-20 07:11:46
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ St
- $630,000 — k will be paid an annual base salary of $630,000 and will be eligible to receive an awar
- $2,500,000 — y award for 2024 with a target value of $2,500,000, effective May 1, 2024, to be issued 50
- $1,250,00 — dollar value of the RSU and PSU awards ($1,250,00 each) by the closing price of a share o
- $1,000,000 — a sign-on equity award with a value of $1,000,000, to be issued in the form of RSUs with
- $125,000 — eceive a one-time cash signing bonus of $125,000, which must be repaid if she voluntaril
Filing Documents
- podd-20240320.htm (8-K) — 38KB
- podd-2024x03x20ex991.htm (EX-99.1) — 12KB
- 0001145197-24-000017.txt ( ) — 176KB
- podd-20240320.xsd (EX-101.SCH) — 2KB
- podd-20240320_lab.xml (EX-101.LAB) — 21KB
- podd-20240320_pre.xml (EX-101.PRE) — 12KB
- podd-20240320_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On March 20, 2024, the Company issued a press release announcing the appointment of the new CFO (as described in Item 5.02 above). A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except in the event that the Company expressly states that such information is to be considered filed under the Exchange Act or incorporates it by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is filed as part of this report: No. Exhibit 99.1 Press release dated March 20, 2024 104 Cover Page Interactive Date File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned thereunto duly authorized. INSULET CORPORATION Date: March 20, 2024 By: /s/ Patricia K. Dolan Name: Patricia K. Dolan Title: Vice President and Secretary